Cochlear Ltd (ASX: COH) and ResMed Inc. (ASX: RMD) shares could be strong buys. Let's see what one leading broker is ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Last month, I caught a bug or allergy of some kind which had me coughing badly for weeks. I don't know about the severity but it was annoying. What was even more annoying was trying to find a decent ...

Chennai: Apollo Children’s Hospitals, Chennai has carried out Tamil Nadu’s first Cochlear™ Nucleus® Nexa™ implant surgery, introducing a new advancement in hearing care in the state. The procedure, ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System - the world's first and only smart cochlear implant system. The new Cochlear™ Nucleus® ...

Cochlear on Monday announced the launch of Cochlear™ Nucleus® Nexa® System in India, describing it as the world’s first and only smart cochlear implant system, coinciding with World Hearing Day.

The market valuation of nine of the top 10 most valued firms eroded by Rs 2,18,902.09 crore last week. Bharti Airtel took the biggest hit in line with a bearish trend in equities with only Hindustan ...